- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03777852
Emotional Evaluation and Reconstructed Breast Satisfaction
April 15, 2019 updated by: Helio Carrara, University of Sao Paulo
Emotional Evaluation and Reconstructed Breast Satisfaction After Breast Cancer Treatment: Breast Q Questionary
Data from the National Cancer Institute (Inca) reveal that breast cancer is the most common type of cancer among women worldwide.
In Brazil, it is second only to non-melanoma skin cancer.
Breast cancer is a feared disease in the female universe because it is considered one of the major causes of death due to neoplasia among women.
It brings also the stigma of suffering, mutilation, loss of female identity and loss of body contour.
Among other issues, problems with body self-image may have an impact on sexuality and fertility, and also, the incapacity to breastfeed.
Breast reconstruction can restore the patient's shape and physical integrity, among other benefits.
The research justifies itself because information about the satisfaction of breast reconstruction can be achieved.
It is also known that women having breast reconstruction after a mastectomy due to cancer have a favorable evolution.
This study will analyze body contour satisfaction of women undergoing mastectomy and breast reconstruction as part of their breast cancer treatment.
The Breast Q questionnaire will be used to measure patients satisfaction.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
This is a prospective, quasi-experimental study.
The subject sample will be composed of women submitted to mastectomy due to breast cancer and to breast reconstruction as part of their treatment.
They will be evaluated twice.
One when they receive the cancer diagnosis and the other six months after de reconstruction surgery.
On both occasions, they will answer the Brest Q questionnaire.
Study Type
Interventional
Enrollment (Anticipated)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Helio HA Carrara, MD, PhD
- Phone Number: 2589 551636021000
- Email: carrara@fmrp.usp.br
Study Contact Backup
- Name: Francisco JC Reis, MD, PhD
- Phone Number: 551636022589
- Email: fjcreis@fmrp.usp.br
Study Locations
-
-
SP
-
Ribeirão Preto, SP, Brazil, 14048900
- Hospital das Clínicas de Ribeirão Preto
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women over eighteen years of age;
- women with proven histological diagnosis of breast cancer;
- women who have an indication of mastectomy as part of their treatment;
- women who have breast reconstruction, regardless of the technique used, as part of their treatment;
- women under 70 years of age at the time of the reconstructive surgery
Exclusion Criteria:
- women diagnosed with breast cancer and treated with conservative surgeries;
- women who refuse reconstruction as part of treatment;
- women who refused surgery as part of the treatment for breast cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Pre-surgery First Breast Q
Women with proven breast cancer diagnosis.
Respond to the First Breast Q questionnaire..
|
Women with breast cancer will respond to the First Breast Q questionnaire before treatment with breast cancer reconstruction surgery.
Other Names:
|
Active Comparator: Post-surgery Second Breast Q
The Second Breast Q questionnaire will be applied to this group that will be composed of the women of the first group submitted to reconstructive breast cancer surgery.
|
Women with breast cancer will respond to the Second Breast Q questionnaire after treatment with breast cancer reconstruction surgery.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-treatment Satisfaction
Time Frame: Six month
|
Comparison of results between the first and the second Breast Q score.
This score represents questionnaries about diferents domains and each question has four possible dimensions.
The values of these dimensions varies from 1 to 4 (Likert Scale).
The sum of each domain raw score scale will be plotted in the Breast Q Conversion Table to convert the summed domain score to a Equivalent Rasch Transformed Score with values ranging from 0 (worst) to 100 (best).
|
Six month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Helio HA Carrara, MD, PhD, Gynecology & Obstetrics Departament, Ribeirão Preto Medical School, USP.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-353. doi: 10.1097/PRS.0b013e3181aee807.
- Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Breast Cancer and Reconstruction: Normative Data for Interpreting the BREAST-Q. Plast Reconstr Surg. 2017 May;139(5):1046e-1055e. doi: 10.1097/PRS.0000000000003241.
- Cohen WA, Mundy LR, Ballard TN, Klassen A, Cano SJ, Browne J, Pusic AL. The BREAST-Q in surgical research: A review of the literature 2009-2015. J Plast Reconstr Aesthet Surg. 2016 Feb;69(2):149-62. doi: 10.1016/j.bjps.2015.11.013. Epub 2015 Nov 26.
- Payne RM, Siotos C, Manahan MA, Rosson GD, Cooney CM. Breast Cancer and Reconstruction: Normative Data for Interpreting the BREAST-Q. Plast Reconstr Surg. 2018 Jan;141(1):180e-181e. doi: 10.1097/PRS.0000000000003970. No abstract available.
- Saiga M, Taira N, Kimata Y, Watanabe S, Mukai Y, Shimozuma K, Mizoo T, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H. Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery. Breast Cancer. 2017 Mar;24(2):288-298. doi: 10.1007/s12282-016-0703-6. Epub 2016 May 14.
- Fuzesi S, Cano SJ, Klassen AF, Atisha D, Pusic AL. Validation of the electronic version of the BREAST-Q in the army of women study. Breast. 2017 Jun;33:44-49. doi: 10.1016/j.breast.2017.02.015. Epub 2017 Mar 7.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2019
Primary Completion (Anticipated)
February 28, 2021
Study Completion (Anticipated)
February 28, 2022
Study Registration Dates
First Submitted
December 14, 2018
First Submitted That Met QC Criteria
December 14, 2018
First Posted (Actual)
December 17, 2018
Study Record Updates
Last Update Posted (Actual)
April 16, 2019
Last Update Submitted That Met QC Criteria
April 15, 2019
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Juçara Phd Thesis
- Helio Carrara (Other Identifier: DGO-FMRP-USP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Neoplasm of the Breast
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Liver | Metastatic Breast Carcinoma | Metastatic Malignant Neoplasm in the Lung and other conditionsUnited States, Canada, Saudi Arabia, Korea, Republic of
-
City of Hope Medical CenterNational Cancer Institute (NCI); California Institute for Regenerative Medicine...RecruitingBreast Cancer | HER2-positive Breast Cancer | Malignant Neoplasm | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
Washington University School of MedicineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedBreast Cancer | Breast Tumors | Cancer of Breast | Malignant Neoplasm of Breast | Cancer of the BreastUnited States
-
National Center for Plastic Surgery, VirginiaWalter Reed Army Medical Center; Ohio State University Comprehensive Cancer... and other collaboratorsCompletedMalignant Neoplasm of the Breast | Acquired Absence of the BreastUnited States
-
National Cancer Institute, ThailandCompleted
-
National Cancer Institute, ThailandCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnBreast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
Isabel BlancasCompletedMalignant Neoplasm of Breast Stage IVSpain
-
Stemline Therapeutics, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
Clinical Trials on First Questionnaire application
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedEvaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk AssessCancer | Cancer Screening Patients | Patient VolunteersUnited States
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingPain | Sedentary Time | Physical InactivityTurkey
-
Halic UniversityBasaksehir Cam & Sakura Şehir Hospital; Istanbul Arel University; Istanbul University...CompletedFeeding Behavior | Breastfeeding | Breast Milk Expression | Support, FamilyTurkey
-
Istanbul University - Cerrahpasa (IUC)CompletedSocial Support, Physical Activity, Validation, ReliabilityTurkey
-
Gazi UniversityCompletedTemporomandibular Joint DisordersTurkey
-
Central Hospital, Nancy, FranceTerminated
-
University Hospital Schleswig-HolsteinZealand University HospitalRecruiting
-
Aga Khan UniversityNot yet recruitingMalnutrition, Child | Malnutrition, InfantPakistan
-
Gazi UniversityRecruitingPrimary Sjögren's SyndromeTurkey
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedGestational Diabetes | Pelvic Girdle Pain | Pregnant WomanTurkey